CRSP

Company News For Oct 12, 2018

  • Delta Air Lines, Inc.'s DAL shares gained 3.6% after reporting third-quarter fiscal 2018 earnings of $1.80 per share, surpassing the Zacks Consensus Estimate of $1.74 per share
  • Shares of Walgreens Boots Alliance, Inc. WBA declined 2% after it reported fourth-quarter fiscal 2018 revenues of $131.53 billion, missing the Zacks Consensus Estimate of $131.60 billion
  • Costco Wholesale Corporation's COST shares increased 0.4% after the company reported net sales of $13.6 billion in September, up 10.3% year-over-year
  • Shares of CRISPR Therapeutics AG CRSP advanced 0.9% after the company announced that a clinical hold on an application for a sickle cell disease treatment developed by Crispr and partner Vertex Pharmaceuticals had been lifted by the Food and Drug Association

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Delta Air Lines, Inc. (DAL): Free Stock Analysis Report

Costco Wholesale Corporation (COST): Free Stock Analysis Report

Walgreens Boots Alliance, Inc. (WBA): Free Stock Analysis Report

CRISPR THERAPTC (CRSP): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.